Ketamine Infusion: A Rapid Remedy for Treatment-Resistant Depression

Rapid Improvement in Depressive Symptoms with Subanesthetic Ketamine

Promising Treatment Option for Treatment-Resistant Depression

According to initial studies, a single subanesthetic-dose IV ketamine infusion has been shown to alleviate depressive symptoms within a day in individuals. Subanesthetic doses of ketamine have proven efficacious as an off-label treatment for severe and treatment-refractory depression. Extensive evidence supports the effectiveness of ketamine in managing treatment-resistant depression (TRD). (Reference: Jelen and Stone, 1. Ketamine for the treatment of major depression. The APA Guidelines on Ketamine Use for Depression)